Teva Pharmaceuticals
TEVA
TEVA
452 hedge funds and large institutions have $5.91B invested in Teva Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 160 increasing their positions, 137 reducing their positions, and 110 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
44% less capital invested
Capital invested by funds: $10.5B → $5.91B (-$4.62B)
54% less funds holding in top 10
Funds holding in top 10: 13 → 6 (-7)
58% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 110
Holders
452
Holding in Top 10
6
Calls
$255M
Puts
$309M
Top Buyers
| 1 | +$66.1M | |
| 2 | +$47.4M | |
| 3 | +$41M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$37.2M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$32.6M |
Top Sellers
| 1 | -$111M | |
| 2 | -$101M | |
| 3 | -$83M | |
| 4 |
PCM
Polaris Capital Management
Boston,
Massachusetts
|
-$70.1M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$64.8M |